greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2023

Novartis AG (NVS) annual results, year to 31 December 2023: revenue USD 45,440 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2023 it reported revenue from the sale of goods of USD 45,440 million, up 7.7% on the year before. Its profit attributable to shareholders was USD 14,850 million, up 113.5%, and diluted earnings per share USD 7.10.

Revenue
USD 45,440 million
+7.7% on the year
FY2016FY2023
Operating margin
21.5%
18.8% a year earlier
FY2016FY2023
Net income
USD 14,850 million
+113.5% on the year
FY2016FY2023
Diluted EPS
USD 7.10
+124.0% on the year
FY2016FY2023

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2022 †Dec 2023
Revenue from the sale of goods42,20645,440
Cost of sales11,58212,472
Gross profit31,87934,188
Research and development9,17211,371
Selling, general and administrative12,19312,517
Operating profit7,9469,769
Profit before tax7,1779,123
Income tax1,128551
Profit for the year6,95514,854
Profit attributable to shareholders6,95514,850
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2022 †Dec 2023
Diluted EPS3.177.10
Basic EPS3.197.15
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2022 †Dec 2023
Cash from operations14,23614,458
Purchase of property, plant and equipment9161,060
Free cash flow13,32013,398
Cash from investing1,4685,596
Cash from financing-20,562-14,278
Buybacks10,6528,719
Dividends paid7,5067,255
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2022 †Dec 2023
Funded by
Equity attributable to shareholders59,34246,667
Non-controlling interests81.083.0
Borrowings, as filed22,48520,627
Lease liabilities1,7891,828
Other liabilities33,75630,740
Total equity and liabilities117,45399,945
Owned
Property, plant and equipment10,7649,514
Goodwill29,30123,341
Other intangible assets31,64426,879
Cash and cash equivalents7,51713,393
Inventories7,1755,913
Other assets31,05220,905
Total assets117,45399,945
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2022 †Dec 2023
Return on year-end equity11.7%31.8%
Effective tax rate15.7%6.0%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2023, filed 4 February 2026: the filing. The figures are in US dollars as filed.